联系方式：400-650-8506
CNEN
产品名称 AT 9283
产品货号 Axon 2219 CAS [896466-04-9] MF C19H23N7O2MW 381.43 Purity: 99% Soluble in water and DMSO Description A multitargeted kinase inhibitor with high affinity for Aurora A and B, JAK2/3, and BCR-Abl(T315I) (IC50 values 3, 3, 1.2, 1.1, and 4 nM respectively). AT 9283 has a potent anti-proliferative activity in a panel of Ba/F3 and human cell lines expressing the BCR-Abl fusion protein or its mutant forms including T315I, and it has the potential to significantly benefit patients with imatinib-resistant CML or with Ph+ ALL. References Certificates Categories Extra info W. Qi et al. AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas. Int. J. Cancer. 2012, 130, 2997-3005.    R. Tanaka et al. Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL-positive leukemic cells. Blood. 2010, 116, 2089-2095.  Certificate of Analysis Material Safety Data Sheet Cell Cycle Regulation Cell Signaling & Oncology Epigenetics Immunology Pain & Inflammation BCR-ABL JAK-STAT EC 2.7.10.2 Aurora JAK Multitargeted kinase inhibitor (Aurora A/B, JAK2/3, and BCR-Abl) Chemical name 1-cyclopropyl-3-(3-(6-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea Parent CAS No. [896466-04-9] Order Size Unit Price Stock 5 mg €85.00 In Stock
产品价格 现货询价，电话：010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

AT 9283

Based on 18 reference(s) in Google Scholar 9 10 18

Axon 2219

CAS [896466-04-9]

MF C19H23N7O2
MW 381.43

  • Purity: 99%
  • Soluble in water and DMSO

AT 9283

Description

A multitargeted kinase inhibitor with high affinity for Aurora A and B, JAK2/3, and BCR-Abl(T315I) (IC50 values 3, 3, 1.2, 1.1, and 4 nM respectively). AT 9283 has a potent anti-proliferative activity in a panel of Ba/F3 and human cell lines expressing the BCR-Abl fusion protein or its mutant forms including T315I, and it has the potential to significantly benefit patients with imatinib-resistant CML or with Ph+ ALL.
产品资料